お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:除細動器の世界市場:現在の分析と予測(2020~2027年)
市場調査レポート
商品コード
984849

除細動器の世界市場:現在の分析と予測(2020~2027年)

Global Defibrillator Market: Current Analysis and Forecast (2020-2027)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 153 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.11円
除細動器の世界市場:現在の分析と予測(2020~2027年)
出版日: 2021年01月25日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 153 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界における除細動器の市場規模は、2019年に100億米ドルと評価され、2021年から2027年にかけて5.2%のCAGRで大幅に拡大すると予測されています。世界の除細動器市場は、世界的な患者数の急増によるヘルスケアセクターでの技術の採用と進歩が、除細動器の導入に対する政府の要求と相まって、促進される見込みです。

当レポートでは、世界の除細動器市場について調査分析し、市場の概要、市場成長への影響要因、各セグメント・地域別による市場規模と前年比成長、および主要企業などについて分析しています。

目次

第1章 市場のイントロダクション

  • 市場定義
  • 調査目的
  • 制限事項
  • ステークホルダー
  • レポートで使用される通貨
  • 調査範囲

第2章 調査手法または前提条件

  • 調査手法
    • 主な目的

第3章 業界のパフォーマンス

第4章 エグゼクティブサマリー

第5章 顧客調査

第6章 COVID-19の影響

第7章 市場考察:製品タイプ別

  • 植込み型除細動器
    • 皮下植込み型除細動器
    • 経静脈植込み型除細動器
  • 体外式除細動器
    • 手動・半自動体外式除細動器
    • 完全自動式外部除細動器
    • 着用型体外式除細動器

第8章 市場考察:エンドユーザー別

  • 病院、診療所、および心臓センター
  • プレホスピタルケア/病院前救護
  • パブリックアクセス市場
  • 代替介護
  • 在宅医療

第9章 市場考察:地域別

  • 北米の除細動器市場
    • 米国
    • カナダ
    • その他の北米
  • 欧州の除細動器市場
    • 英国
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の除細動器市場
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • その他

第10章 除細動器市場の市場力学

  • 市場の促進要因
  • 市場の課題
  • 影響分析

第11章 法的および規制の枠組み

第12章 需要サイド・供給サイドの分析

  • 需要サイド分析
  • 供給サイド分析
    • 主な製品の発売
    • 主なビジネスパートナーシップ
    • 主な合併と買収
    • 主な事業拡大と投資

第13章 バリューチェーン分析

第14章 除細動器市場のホットスポット&機会

第15章 除細動器市場動向&考察

第16章 競合シナリオ

  • ポーターのファイブフォース分析
  • 競合情勢
  • 競合マトリックス

第17章 企業概要

  • Koninklijke Philips NV
    • 重要データ
    • 事業内容
    • 主要な製品/サービスの提供
    • 成長戦略
    • SWOT分析
    • 主要な財務
    • 最近の動向
  • Nihon Kohden Corporation
  • Progetti SRL
  • Schiller AG
  • ST Jude Medical (Acquired By Abbott Laboratories)
  • Zoll Medical Corporation (A Part of Asahi Kasei Corporation)
  • Cardiac Science
  • Boston Scientific Corporation
  • Physio-Control (Part of Stryker Corporation)
  • Medtronic

第18章 免責事項

目次
Product Code: UMHE21197

The defibrillator is a device that sends electrical energy, or shock, to the heart. The major goal of using a defibrillator is to treat cardiac arrest. In the emergency treatment for ventricular fibrillation and other life-threatening arrhythmias (abnormal heartbeats), defibrillators are being used. Proliferating incidence of sudden cardiac arrest coupled with the rise in the patients related to cardiovascular disease across the globe is resulting in the demand for defibrillators. As per the World Health Organization (WHO), disease-related to cardio is the leading cause of death worldwide. Every approximately 17.9 million deaths happen due to CVDs every year. Also, in one year alone, 475,000 Americans die from a cardiac arrest and 30,000 Hospital Cardiac Arrests occur every year in the UK. Also, it was found that sudden cardiac death (SCD) accounts for up to 20% of deaths in Western societies and Without immediate treatment, 90-95% of sudden cardiac arrest victims die.

Owing to a surge in the number of out of hospital cardiac arrest the government across countries has mandated the installation of a defibrillator in public places, As per the American Heart Association, over 356,000 out-of-hospital cardiac arrest incidences happened annually in the united states and approximately 90% of them are fatal. Also, Approximately 30,000 out of Hospital Cardiac Arrests occur every year in the UK and 270 children die in the UK every year after suffering a Sudden Cardiac Arrest at school.

Moreover, a rise in the geriatric population worldwide is leading to a demand for Defibrillators. As per the United Nations, there were 703 million persons aged 65 years or over in the world in 2019 and the number of older persons is projected to double to 1.5 billion in 2050. As per a conducted by the U.S. National Library of Medicine National Institutes of Health at the incidence of sudden cardiac arrest markedly increases with age, from 100 per 100,000 for 50-year-old patients to 800 per 100,000 for 75-year-old patients in Chicago, USA.

The changing lifestyle coupled with the busy and hectic lifestyle has led to the adoption of a sedentary lifestyle, due to which the prevalence of cardiovascular disease is on the rise. As per the American heart association, 99% of Americans need to improve their heart health, out of that 56% of adults have been told to improve their health. Therefore, with the growing awareness among end-users, the demand and deployment of defibrillators are on the rise. In a report, it was found that for every minute that goes by where a victim of Sudden Cardiac Arrest does not receive treatment, their chances of survival decrease by 10% while In the United Kingdom, the emergency services average response time to a cardiac event related incident in an urban area is 11 minutes. Therefore, the need for immediate treatment of the victim of sudden cardiac arrest is the key contributing factor to the growth of the market.

Based on the product, the defibrillator market is bifurcated into implantable cardioverter defibrillators and external defibrillators. The implantable cardioverter defibrillators segment generated revenue of US$ 10.0 billion in 2019. The market for the implantable cardioverter defibrillators segment is expected to grow at a CAGR of 3.3% during the forecast period to reach a market valuation of US$ 9.0 billion by 2027. However, the external defibrillators market is expected to witness the highest CAGR growth during the forecast period 2021-2027.

Amongst implantable cardioverter defibrillators type, the market is fragmented into subcutaneous implantable cardioverter defibrillators and transvenous implantable cardioverter defibrillators. The transvenous implantable cardioverter defibrillators segment generated revenue of US$ 5.6 billion in 2019. The market is expected to grow at a CAGR of 3.5% during the forecast period to reach a market valuation of US$ 7.6 billion by 2027.

Amongst the external defibrillators market, the market is fragmented into manual & semi-automated external defibrillators, fully automated external defibrillators, and wearable cardioverter-defibrillators. The fully automated external defibrillators segment generated revenue of US$ 1.5 billion in 2019. The market is expected to grow at a CAGR of 8.5% during the forecast period to reach a market valuation of US$ 3.0 billion by 2027.

Based on end-users, the defibrillator market is fragmented into hospitals, clinics, & cardiac Centers, Pre-hospital care settings, Public access market, Alternate care market, and Homecare settings. The Hospitals, clinics, & cardiac Centers segment generated revenue of US$ 8.8 billion in 2019. The market is expected to grow at a CAGR of 5.4 % during the forecast period to reach a market valuation of US$ 13.8 billion by 2027.

For a better understanding of the market penetration of global defibrillators, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and Rest of the World. North America constitutes a major market for defibrillators.

Some of the major players operating in the market include: Koninklijke Philips N.V., Nihon Kohden Corporation, Progetti SRL, Schiller AG, ST. Jude Medical (Acquired By Abbott Laboratories), Zoll Medical Corporation (A Part of Asahi Kasei Corporation), Cardiac Science, Boston Scientific Corporation, Physio-Control (Part of Stryker Corporation), and Medtronic.

The global defibrillators market was valued at US$ 10.0 billion in 2019 and is projected to expand significantly with a CAGR of 5.2% from 2021 to 2027. The global defibrillator market is expected to witness a boost, owing to the adoption and advancement in technologies in the healthcare sector due to the surging number of patients across the globe coupled with the government's mandate for the deployment of defibrillators.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Defibrillator Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Defibrillator Market
    • 2.1.1 Main Objective of the Global Defibrillator Market

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 CUSTOMER SURVEY

6 COVID-19 IMPACT

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1 Implantable Cardioverter Defibrillators
    • 7.1.1 Subcutaneous Implantable Cardioverter Defibrillators
    • 7.1.2 Transvenous Implantable Cardioverter Defibrillators
  • 7.2 External Defibrillators
    • 7.2.1 Manual & Semi-Automated External Defibrillators
    • 7.2.2 Fully Automated External Defibrillators
    • 7.2.3 Wearable Cardioverter Defibrillators

8 MARKET INSIGHTS BY END-USERS

  • 8.1 Hospitals, Clinics, & Cardiac Centres
  • 8.2 Pre-Hospital Care Settings
  • 8.3 Public Access Market
  • 8.4 Alternate Care Market
  • 8.5 Home Care Settings

9 MARKET INSIGHTS BY REGION

  • 9.1 North America Defibrillator Market
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Rest of North America
  • 9.2 Europe Defibrillator Market
    • 9.2.1 The United Kingdom
    • 9.2.2 France
    • 9.2.3 Germany
    • 9.2.4 Spain
    • 9.2.5 Italy
    • 9.2.6 Rest of Europe
  • 9.3 Asia Pacific Defibrillator Market
    • 9.3.1 China
    • 9.3.2 India
    • 9.3.3 Japan
    • 9.3.4 Australia
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia Pacific
  • 9.4 Rest of the World Defibrillator Market

10 DEFIBRILLATOR MARKET DYNAMICS

  • 10.1 Market Drivers
  • 10.2 Market Challenges
  • 10.3 Impact Analysis

11    LEGAL & REGULATORY FRAMEWORK

12    DEMAND AND SUPPLY SIDE ANALYSIS

  • 12.1 Demand Side Analysis
  • 12.2 Supply Side Analysis
    • 12.2.1 Top Product Launches
    • 12.2.2 Top Business Partnerships
    • 12.2.3 Top Merger & Acquisitions
    • 12.2.4 Top Business Expansions and Investments

13 VALUE CHAIN ANALYSIS

14 DEFIBRILLATOR MARKET HOTSPOT & OPPORTUNITIES

15 DEFIBRILLATOR MARKET TRENDS & INSIGHTS

16 COMPETITIVE SCENARIO

  • 16.1 Porter's Five forces analysis
    • 16.1.1 Bargaining power of Supplier
    • 16.1.2 Bargaining power of Buyer
    • 16.1.3 Industry Rivalry
    • 16.1.4 Availability of Substitute
    • 16.1.5 Threat of new Entrants
  • 16.2 Competitive Landscape
    • 16.2.1 Company Shares, By Revenue
  • 16.3 Competition Matrix
    • 16.3.1 Product/Service Portfolio
    • 16.3.2 Target Markets
    • 16.3.3 Target End Users
    • 16.3.4 Research & Development
    • 16.3.5 Strategic Alliances

17 COMPANY PROFILED

  • 17.1 Koninklijke Philips NV
    • 17.1.1 Key Facts
    • 17.1.2 Business Description
    • 17.1.3 Key Product/Services Offerings
    • 17.1.4 Growth Strategy
    • 17.1.5 SWOT Analysis
    • 17.1.6 Key Financials
      • 17.1.6.1
      • 17.1.6.2
    • 17.1.7 Recent Developments
      • 17.1.7.1
      • 17.1.7.2
      • 17.1.7.3
      • 17.1.7.4
  • 17.2 Nihon Kohden Corporation
  • 17.3 Progetti SRL
  • 17.4 Schiller AG 
  • 17.5 ST Jude Medical (Acquired By Abbott Laboratories)
  • 17.6 Zoll Medical Corporation (A Part of Asahi Kasei Corporation)
  • 17.7 Cardiac Science
  • 17.8 Boston Scientific Corporation
  • 17.9 Physio-Control (Part of Stryker Corporation)
  • 17.10 Medtronic

18 DISCLAIMER

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.